Page last updated: 2024-08-17

desoxycorticosterone and allopurinol

desoxycorticosterone has been researched along with allopurinol in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19902 (16.67)18.7374
1990's0 (0.00)18.2507
2000's5 (41.67)29.6817
2010's5 (41.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL1
Da Silva, O; Kourounakis, P; Selye, H; Szabo, S1
Selye, H1
Chen, AF; Fink, GD; Galligan, JJ; Li, L; Northcott, CA; Pagano, PJ; Watts, SW1
Banes, AK; Chen, AF; Fink, GD; Galligan, JJ; Li, L; Watts, SW1
Ghosh, M; McNeill, JR; Wang, HD1
Callera, GE; Montezano, AC; Tostes, RC; Touyz, RM; Yogi, A1
Benkirane, K; Javeshghani, D; Schiffrin, EL; Touyz, RM; Viel, EC1
Szasz, T; Watts, SW1
Burnett, R; Davis, RP; Fink, GD; Linder, AE; Szasz, T; Watts, SW1
Burnett, RJ; Davis, RP; Fink, GD; Garver, HS; Szasz, T; Watts, SW1
Amaral, JH; Ferreira, GC; Montenegro, MF; Pinheiro, LC; Tanus-Santos, JE1

Other Studies

12 other study(ies) available for desoxycorticosterone and allopurinol

ArticleYear
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
    PloS one, 2016, Volume: 11, Issue:10

    Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat

2016
Pharmacodynamic interactions among gluco-, mineralo- and glucomineralocorticoids, pregnenolone-16alpha-carbonitrile and various drugs.
    The Journal of pharmacology and experimental therapeutics, 1974, Volume: 188, Issue:1

    Topics: Acetanilides; Allopurinol; Aniline Compounds; Animals; Arsenicals; Barbiturates; Carisoprodol; Corticosterone; Desoxycorticosterone; Drug Interactions; Female; Fludrocortisone; Glucocorticoids; Gold Sodium Thiomalate; Mephenesin; Mineralocorticoids; Morphinans; Motor Activity; Pancuronium; Picrotoxin; Pregnenolone Carbonitrile; Rats; Strychnine; Triamcinolone; Zoxazolamine

1974
Protection by glucocorticoids against allopurinol nephropathy.
    Acta endocrinologica, 1972, Volume: 69, Issue:2

    Topics: Allopurinol; Animals; Desoxycorticosterone; Estradiol; Ethylestrenol; Female; Kidney; Kidney Diseases; Oxandrolone; Prednisolone; Pregnanediones; Progesterone; Rats; Spironolactone; Triamcinolone

1972
Endothelin-1 increases vascular superoxide via endothelin(A)-NADPH oxidase pathway in low-renin hypertension.
    Circulation, 2003, Feb-25, Volume: 107, Issue:7

    Topics: Animals; Blood Pressure; Carotid Arteries; Desoxycorticosterone; Endothelin Receptor Antagonists; Endothelin-1; Hypertension; Male; NADPH Oxidases; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; Receptors, Endothelin; Renin; Signal Transduction; Superoxide Dismutase; Superoxides; Transduction, Genetic; Xanthine Oxidase

2003
NADPH oxidase-derived superoxide augments endothelin-1-induced venoconstriction in mineralocorticoid hypertension.
    Hypertension (Dallas, Tex. : 1979), 2003, Volume: 42, Issue:3

    Topics: Acetophenones; Allopurinol; Animals; Atrasentan; Desoxycorticosterone; Dose-Response Relationship, Drug; Endothelin A Receptor Antagonists; Endothelin Receptor Antagonists; Endothelin-1; Enzyme Inhibitors; Hypertension; In Vitro Techniques; Male; NADPH Oxidases; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Mineralocorticoid; Superoxides; Vasoconstriction; Vasoconstrictor Agents; Venae Cavae; Viper Venoms; Xanthine Oxidase

2003
Role of oxidative stress and nitric oxide in regulation of spontaneous tone in aorta of DOCA-salt hypertensive rats.
    British journal of pharmacology, 2004, Volume: 141, Issue:4

    Topics: Acridines; Animals; Aorta, Thoracic; Blood Pressure; Blotting, Western; Calcium; Catalase; Cyclooxygenase Inhibitors; Desoxycorticosterone; Endothelium, Vascular; Hydrogen Peroxide; Hypertension; Immunohistochemistry; In Vitro Techniques; Luminescent Measurements; Male; Muscle Contraction; Muscle Tonus; Muscle, Smooth, Vascular; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Oligopeptides; Oxidative Stress; Oxygen; Peptides, Cyclic; Piperidines; Rats; Rats, Sprague-Dawley; Receptors, Thromboxane; Superoxides; Tyrosine; Xanthine Oxidase

2004
Endothelin-1-induced oxidative stress in DOCA-salt hypertension involves NADPH-oxidase-independent mechanisms.
    Clinical science (London, England : 1979), 2006, Volume: 110, Issue:2

    Topics: Animals; Antihypertensive Agents; Aorta; Dansyl Compounds; Desoxycorticosterone; Endothelin A Receptor Antagonists; Endothelin-1; Endothelium, Vascular; Hypertension; Male; Mesenteric Arteries; Mitochondria; Models, Animal; Myocardium; NADPH Oxidases; Nitric Oxide Synthase Type III; Oxidative Stress; Rats; Rats, Wistar; Receptor, Endothelin A; Sodium Chloride, Dietary; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances; Xanthine Oxidase

2006
Xanthine oxidase and mitochondria contribute to vascular superoxide anion generation in DOCA-salt hypertensive rats.
    American journal of physiology. Heart and circulatory physiology, 2008, Volume: 295, Issue:1

    Topics: Animals; Antihypertensive Agents; Aorta; Blood Pressure; Creatinine; Desoxycorticosterone; Disease Models, Animal; Endothelin Receptor Antagonists; Endothelin-1; Enzyme Inhibitors; Free Radical Scavengers; Hypertension; Lipid Peroxidation; Male; Mesenteric Arteries; Mitochondria; NADPH Oxidases; Nephrectomy; Oxidative Phosphorylation; Rats; Rats, Sprague-Dawley; Receptors, Endothelin; Superoxides; Thiobarbituric Acid Reactive Substances; Uncoupling Agents; Uric Acid; Vascular Resistance; Xanthine Oxidase

2008
Uric acid does not affect the acetylcholine-induced relaxation of aorta from normotensive and deoxycorticosterone acetate-salt hypertensive rats.
    The Journal of pharmacology and experimental therapeutics, 2010, Volume: 333, Issue:3

    Topics: Acetylcholine; Animals; Antioxidants; Aorta, Thoracic; Blotting, Western; Desoxycorticosterone; Endothelium, Vascular; Enzyme Inhibitors; Hypertension; Male; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Rats; Rats, Sprague-Dawley; Sodium Chloride; Urate Oxidase; Uric Acid; Vasodilator Agents; Xanthine Oxidase

2010
Allopurinol does not decrease blood pressure or prevent the development of hypertension in the deoxycorticosterone acetate-salt rat model.
    Journal of cardiovascular pharmacology, 2010, Volume: 56, Issue:6

    Topics: Allopurinol; Animals; Blood Pressure; Desoxycorticosterone; Disease Models, Animal; Enzyme Inhibitors; Hypertension; Male; Rats; Rats, Sprague-Dawley; Xanthine Oxidase

2010
Long-term inhibition of xanthine oxidase by febuxostat does not decrease blood pressure in deoxycorticosterone acetate (DOCA)-salt hypertensive rats.
    PloS one, 2013, Volume: 8, Issue:2

    Topics: Animals; Blood Pressure; Desoxycorticosterone; Febuxostat; Hypertension; Male; Rats; Rats, Sprague-Dawley; Thiazoles; Xanthine Oxidase

2013
Consistent antioxidant and antihypertensive effects of oral sodium nitrite in DOCA-salt hypertension.
    Redox biology, 2015, Volume: 5

    Topics: Animals; Antihypertensive Agents; Antioxidants; Blood Pressure; Desoxycorticosterone; Dinoprost; Disease Models, Animal; Hypertension; Lipid Peroxides; Male; NADPH Oxidases; Nitrites; Nitrogen Oxides; Oxidative Stress; Rats; Rats, Wistar; Reactive Oxygen Species; Sodium Nitrite; Xanthine Oxidase

2015